decisionhealth Newsletters, Part B News - 2007 Issue 12 (December)
Prices continue to yo-yo for some high volume drugs
Subscribe or sign in to view the full article.
Article Overview
This article reviews Medicare Part B drug pricing changes under the average sales price reimbursement formula for the 2008 update cycle. It discusses broad price movement patterns, the addition and deletion of drug entries, and several code changes affecting injectable drugs and contrast agents. The piece is most relevant to coding and reimbursement professionals tracking Part B drug billing updates.
Why This Topic Matters
Changes to the ASP list can affect drug billing, reimbursement expectations, and code maintenance for practices that bill Medicare Part B drugs and injectables. Staying current helps billing teams recognize when codes are added, removed, or recoded during the annual update process.
What You Will Learn
- How Medicare Part B drug pricing changes are being described for the 2008 update period.
- What categories of drugs experienced price increases, decreases, or no change.
- How the ASP list was updated with new, retired, and recoded drug entries.
- Which broad types of injectable drugs and contrast agents are affected by the update.
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Compliance staff
- Physician practice administrators
- Pharmacy billing professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com